Showing results (81-90 of 887) with videos related to
Sort By:
Pageof 89
Drugs in R&D|June 21, 2006
The potential of plant virus vectors for vaccine productionVidadi Yusibov, Shailaja Rabindran, Ulrich Commandeur, et al.Drugs in R&D|June 21, 2006
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonistReyes Corcóstegui, Luis Labeaga, Ana Innerárity, et al.Drugs in R&D|June 7, 2006
Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--DendreonDrugs in R&D|July 1, 2008
Adaptive clinical trials: progress and challengesChristopher S Coffey, John A KairallaDrugs in R&D|July 3, 2004
Effects of propionyl-carnitine in patients with type 2 diabetes and peripheral vascular disease: results of a pilot trialGiovanni Ragozzino, Edi Mattera, Elisa Madrid, et al.Drugs in R&D|July 3, 2004
Apomorphine-subcutaneous--Bertek/BritanniaDrugs in R&D|March 22, 2005
Should non-nucleoside reverse transcriptase inhibitors be combined?Bregt S Kappelhoff, Alwin D R Huitema, Jos H BeijnenDrugs in R&D|March 22, 2005
Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokersIlknur Basyigit, Fusun Yildiz, Mustafa Cekmen, et al.Drugs in R&D|July 5, 2005
Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skinKlaus Schaffler, Peter Reitmeir, Andrea Gschanes, et al.Drugs in R&D|July 5, 2005
Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093)Joana Maia, Manuel Vaz-da-Silva, Luis Almeida, et al.Pageof 89